Several nested case-control studies have examined the
archival smears of women with invasive cervical cancer and
of control women.
In all of them, a higher prevalence of
HPV-16DNAwas detected in the smears and diagnostic biopsies
of women who subsequently developed cervical cancer
than in smears from control women without cervical cancer.
The risk of types other than HPV-16 was difficult to assess